Taro extracts have also demonstrated anti-inflammatory activity against human and murine breast cancer cells by modulating the immune response through the reduction of prostaglandin E2 (PGE2) release accompanied by the abolishment of mRNA synthesis of cyclooxygenase-2 (COX-2), and decrease of COX-1 [42]. Here, PTGS2 is linked to breast carcinoma.